Kynurenic Acid/AhR Signaling at the Junction of Inflammation and Cardiovascular Diseases
International Journal of Molecular Sciences · 25.06.2024 · 25 (13) · 6933
DOI: 10.3390/ijms25136933 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.06.2024. Verfasst von Alevtina Y Grishanova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine, Timakova Str. 2, Novosibirsk 630060…. Hauptthemen laut MEDLINE: Receptors, Aryl Hydrocarbon, Cardiovascular Diseases, Signal Transduction, Kynurenic Acid. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 351 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The work was supported by the Ministry of Science and Higher Education of the Russian Federation, Ministry of Science and Higher Education of the Russian Federation.
Abstract (Originalsprache)
Persistent systemic chronic inflammatory conditions are linked with many pathologies, including cardiovascular diseases (CVDs), a leading cause of death across the globe. Among various risk factors, one of the new possible contributors to CVDs is the metabolism of essential amino acid tryptophan. Proinflammatory signals promote tryptophan metabolism via the kynurenine (KYN) pathway (KP), thereby resulting in the biosynthesis of several immunomodulatory metabolites whose biological effects are associated with the development of symptoms and progression of various inflammatory diseases. Some participants in the KP are agonists of aryl hydrocarbon receptor (AhR), a central player in a signaling pathway that, along with a regulatory influence on the metabolism of environmental xenobiotics, performs a key immunomodulatory function by triggering various cellular mechanisms with the participation of endogenous ligands to alleviate inflammation. An AhR ligand with moderate affinity is the central metabolite of the KP: KYN; one of the subsequent metabolites of KYN—kynurenic acid (KYNA)—is a more potent ligand of AhR. Understanding the role of AhR pathway-related metabolites of the KP that regulate inflammatory factors in cells of the cardiovascular system is interesting and important for achieving effective treatment of CVDs. The purpose of this review was to summarize the results of studies about the participation of the KP metabolite—KYNA—and of the AhR signaling pathway in the regulation of inflammation in pathological conditions of the heart and blood vessels and about the possible interaction of KYNA with AhR signaling in some CVDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Biology and Biophysics, Federal Research Center of Fundamental and Translational Medicine, Timakova Str. 2, Novosibirsk 630060, Russia.
ORCID-Profile: Alevtina Y Grishanova
Förderung
- The work was supported by the Ministry of Science and Higher Education of the Russian Federation
- Ministry of Science and Higher Education of the Russian Federation
Zitieren
APA
Grishanova, A. Y., & Perepechaeva, M. L. (2024). Kynurenic Acid/AhR Signaling at the Junction of Inflammation and Cardiovascular Diseases. International Journal of Molecular Sciences, 25(13), 6933. https://doi.org/10.3390/ijms25136933
Vancouver
Grishanova AY, Perepechaeva ML. Kynurenic Acid/AhR Signaling at the Junction of Inflammation and Cardiovascular Diseases. International Journal of Molecular Sciences. 2024;25(13):6933. doi:10.3390/ijms25136933
BibTeX
@article{Grishanova2024,
author = {Grishanova, Alevtina Y and Perepechaeva, Maria L},
title = {Kynurenic Acid/AhR Signaling at the Junction of Inflammation and Cardiovascular Diseases},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {6933},
doi = {10.3390/ijms25136933}
}
EUVIMED